perhexiline and glycine

perhexiline has been researched along with glycine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (83.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Horowitz, JD; Kennedy, JA; Kiosoglous, AJ; Murphy, GA; Pelle, MA	1
Horowitz, JD; Kennedy, JA; McFadden-Lewis, K; Minerds, K; Murphy, GA; Unger, SA	1
Abozguia, K; Clarke, K; Frenneaux, M; Lee, L	1
Agulló, E; Barba, I; Chavarria, L; Garcia-Dorado, D; Mirabet, M; Ruiz-Meana, M	1

Reviews

1 review(s) available for perhexiline and glycine

Article	Year
Modification of myocardial substrate use as a therapy for heart failure. Nature clinical practice. Cardiovascular medicine, 2006, Volume: 3, Issue:9 Topics: Acetanilides; Adrenergic beta-Antagonists; Animals; Cardiac Output, Low; Cardiovascular Agents; Energy Metabolism; Epoxy Compounds; Fatty Acids, Nonesterified; Glycine; Heart; Humans; Myocardium; Oxygen; Perhexiline; Piperazines; Ranolazine; Trimetazidine	2006

Article

Year

Modification of myocardial substrate use as a therapy for heart failure.

Nature clinical practice. Cardiovascular medicine, 2006, Volume: 3, Issue:9

Topics: Acetanilides; Adrenergic beta-Antagonists; Animals; Cardiac Output, Low; Cardiovascular Agents; Energy Metabolism; Epoxy Compounds; Fatty Acids, Nonesterified; Glycine; Heart; Humans; Myocardium; Oxygen; Perhexiline; Piperazines; Ranolazine; Trimetazidine

2006

Other Studies

5 other study(ies) available for perhexiline and glycine

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart. Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:6 Topics: Animals; Calcium Channel Blockers; Carnitine O-Palmitoyltransferase; Coronary Circulation; Enzyme Inhibitors; Glycine; Heart; Heart Rate; Hemodynamics; In Vitro Techniques; Lactic Acid; Male; Malonyl Coenzyme A; Myocardium; Perhexiline; Rats; Rats, Sprague-Dawley; Reperfusion Injury	2000
Dissociation between metabolic and efficiency effects of perhexiline in normoxic rat myocardium. Journal of cardiovascular pharmacology, 2005, Volume: 46, Issue:6 Topics: Animals; Carnitine O-Palmitoyltransferase; Cells, Cultured; Enzyme Inhibitors; Glucose; Glycine; Heart Rate; Myocytes, Cardiac; Oxidation-Reduction; Palmitic Acid; Perhexiline; Rats; Rats, Sprague-Dawley; Rats, Wistar	2005
Effect of intracellular lipid droplets on cytosolic Ca2+ and cell death during ischaemia-reperfusion injury in cardiomyocytes. The Journal of physiology, 2009, Mar-15, Volume: 587, Issue:Pt 6 Topics: Animals; Calcium; Cell Death; Cell Hypoxia; Cell Line; Cells, Cultured; Cytoplasmic Granules; Cytosol; Fatty Acids, Nonesterified; Flow Cytometry; Glycine; Lipid Metabolism; Magnetic Resonance Spectroscopy; Male; Mice; Myocytes, Cardiac; Oleic Acid; Perhexiline; Rats; Rats, Sprague-Dawley; Reperfusion Injury	2009